- Home
- TRIP vs CLDX Comparison
TRIP vs CLDX Comparison
Compare TRIP & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TRIP | CLDX |
|---|---|---|
| Founded | 2000 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.9B |
| IPO Year | 2011 | 2008 |
Fundamental Metrics
Financial Performance| Metric | TRIP | CLDX |
|---|---|---|
| Price | $15.24 | $29.45 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 9 | 10 |
| Target Price | $16.25 | ★ $43.80 |
| AVG Volume (30 Days) | ★ 2.5M | 798.4K |
| Earning Date | 11-06-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 124.53 | N/A |
| EPS | ★ 0.59 | N/A |
| Revenue | ★ $1,891,000,000.00 | $2,599,000.00 |
| Revenue This Year | $5.18 | N/A |
| Revenue Next Year | $5.08 | $19.70 |
| P/E Ratio | $26.15 | ★ N/A |
| Revenue Growth | ★ 4.25 | N/A |
| 52 Week Low | $10.43 | $14.40 |
| 52 Week High | $20.16 | $29.83 |
Technical Indicators
Market Signals| Indicator | TRIP | CLDX |
|---|---|---|
| Relative Strength Index (RSI) | 50.50 | 67.48 |
| Support Level | $14.56 | $25.69 |
| Resistance Level | $15.40 | $27.03 |
| Average True Range (ATR) | 0.62 | 1.32 |
| MACD | 0.11 | 0.48 |
| Stochastic Oscillator | 91.59 | 93.11 |
Price Performance
Historical ComparisonAbout TRIP TripAdvisor Inc.
Tripadvisor is the world's leading travel metasearch company. Its platform offers 1 billion reviews and information on several million accommodations, restaurants, experiences, airlines, and cruises. In 2024, 52% of revenue came from the company's core Brand Tripadvisor segment, which includes hotel revenue generated through advertising on its metasearch platform. Viator, its experiences brand, was 46% of sales in 2024, and TheFork, its dining brand, represented 10% of revenue (about 8% of sales were intersegment, which are eliminated from consolidated revenue).
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.